News outlets focus on one dramatic outcome. But did researchers omit data from hundreds in clinical trial?
Cancer misinformation in various media irks breast cancer patients in US & UK
One cancer patient’s dramatic response to immunotherapy. But …
Are the clinical trial results for breast cancer drug taselisib ‘incredibly exciting’ or ‘disappointing’?
As world’s largest cancer conference gets underway, keep these three tweets in mind
Patient harm from ads for Opdivo and other cancer immunotherapies
Turning 40? You might want to skip this mammography primer from U.S. News
ASCO 2018: How a major medical meeting uses embargoes to shape the news, and what the consequences may be
A breast cancer study in mice gets big headlines, setting up potential for patient ‘disaster,’ experts say
A cancer doctor speaks out: How premature hype about experimental drugs fails patients